Recent Events & Catalysts
Medline Inc. (MDLN) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
No committee signals recorded yet.
News
Wells Fargo Maintains Equal-Weight on Medline, Lowers Price Target to $34
Benzinga · today
TD Cowen Maintains Buy on Medline, Lowers Price Target to $45
Benzinga · 1d ago
RBC Capital Maintains Outperform on Medline, Lowers Price Target to $46
Benzinga · 5d ago
Truist Securities Maintains Buy on Medline, Lowers Price Target to $47
Benzinga · 5d ago
Evercore ISI Group Maintains Outperform on Medline, Lowers Price Target to $39
Benzinga · 5d ago
Stifel Maintains Buy on Medline, Lowers Price Target to $45
Benzinga · 5d ago
Allspring Growth Fund Q2 2026 Performance Update
SeekingAlpha · 5d ago
Medline Inc. (MDLN) Q2 2026 Earnings Call Transcript
SeekingAlpha · 6d ago
SEC Filings (90 days)
Results of operations (earnings release), Financial statements and exhibits
Filed 2026-08-05 · 6d ago · Material
Departure/appointment of directors or officers
Filed 2026-07-09 · 33d ago
Submission of matters to a vote of security holders
Filed 2026-06-12 · 60d ago
Entry into a material agreement, Creation of a direct financial obligation (new debt), Other events, Financial statements and exhibits
Filed 2026-06-02 · 70d ago
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.